Purdue Scientists Join in Launch of Cloud-based Canine Cancer Database to Benefit Humans and Their Best Friends

The National Cancer Institute has announced the development of the Integrated Canine Data Commons (ICDC), which has significant ties to the Purdue University College of Veterinary Medicine. Developed by the Frederick National Laboratory for Cancer Research, the cloud-based repository of spontaneously arising canine cancer data was created with the goal of advancing human cancer research by enabling comparative analysis of canine cancer. Dr. Deborah Knapp, Distinguished Professor and the Dolores L. McCall Professor of Comparative Oncology in the Department of Veterinary Clinical Sciences, serves on the Steering Committee for the ICDC, as one of the external researchers from institutions of higher education invited to participate.

The cloud-based repository of spontaneously arising canine cancer data was created with the goal of advancing human cancer research by enabling comparative analysis of canine cancer.

“Many different types of information on dog tumors, including genomics, pathology, clinical features, and case outcomes can be deposited into the ICDC,” Dr. Knapp explains. “Scientists from all over the world can study the information from dogs and compare it with human cancer patient data from the Cancer Research Data Commons. This is expected to lead to a much better understanding of the similarities and differences between canine and human cancer and better outcomes for cancer patients in both species.” Dr. Knapp adds, “It is an honor to participate with top scientists at the National Cancer Institute who are leading this effort.”  

In addition to Dr. Knapp, other scientists from Purdue have been involved, specifically in contributing two of the initial data sets in the ICDC. Dr. Deepika Dhawan, oncology research scientist in the Purdue Comparative Oncology Program, and Dr. Sagar Utturkar, senior bioinformatics scientist in the Bindley Bioscience Center, have been heavily involved in compiling, analyzing, and formatting the Purdue data the team has contributed to the ICDC. Dr. Tim Ratliff, Distinguished Professor of Comparative Pathobiology and the Robert Wallace Miller Director of the Purdue University Center for Cancer Research, was instrumental in connecting the Purdue team to the program.

The ICDC and its website were publicly launched August 26, 2020 in conjunction with National Dog Day. Click here to learn more.

The National Cancer Institute (NCI) is the federal government’s principal agency for cancer research and training. The NCI coordinates the United States National Cancer Program and is part of the National Institutes of Health, which is one of eleven agencies that are part of the U.S. Department of Health and Human Services. The ICDC is part of the Cancer Research Data Commons (CRDC), an initiative from NCI’s Center for Biomedical Informatics and Information Technology (CBIIT). Learn more at cancer.gov.

Writer(s): Allison Carey | pvmnews@purdue.edu

Recent Stories

Purdue Veterinary Medicine’s Connection with Wildlife Rescue in Guatemala Highlighted during International Education Week

Hidden amid the dense forests near the shores of Lake Petén Itzá, the ARCAS Wildlife Rescue Center is one of Central America’s most active sanctuaries for endangered and trafficked wildlife. In addition to their conservation efforts, ARCAS (Asociación de Rescate y Conservación de Vida Silvestre) offers unparalleled hands-on experience for veterinary and biology students from around the world. The Purdue University College of Veterinary Medicine has proudly collaborated with ARCAS for many years, and International Education Week this week (November 16-22) provided the perfect opportunity to showcase this invaluable educational partnership.

Immersive Mixed Reality Experience Helps Purdue Veterinary Students Learn Cardiac Physiology

First year Doctor of Veterinary Medicine students at the Purdue University College of Veterinary Medicine recently stepped into a new era of learning — an immersive Mixed Reality (MR) experience at Purdue’s Envision Center. This cutting-edge session allowed students to interact with a dynamic, 3D representation of the heart, deepening their understanding of cardiac physiology in ways traditional methods cannot match.

Feathered Fame: Purdue Veterinary Medicine Research Featured on Journal Cover

The Department of Veterinary Clinical Sciences (VCS) at Purdue University is proud to announce that a recent study from its anesthesiology team has been selected as the cover feature for Veterinary Sciences (MDPI), Volume 12, Issue 11. Chosen from among 82 articles, the publication highlights the College of Veterinary Medicine’s growing impact in avian clinical research.

“Paws Up” – brought to you by the PVM Wellness Committee

Time to shine a spotlight on some “paws-itively” amazing work by one of our newest Purdue Veterinary Medicine staff members, Jennifer Hartman, VCS Curriculum Technologist in the Department of Veterinary Clinical Sciences.

“Paws Up” – brought to you by the PVM Wellness Committee

Today we are highlighting Rebecca Hoffman, BS, RVT, who is a veterinary technologist with the Bovine Field Service.

Learning Specialist Joins PVM Student Success Center Team

Purdue Veterinary Medicine’s Student Success Center is pleased to welcome Kelsey Luse Spille, who joined the team Monday, November 4, as a learning specialist.  In her new role, she will be supporting students with their academic needs while also serving as a member of the Veterinary Education Support Team (VEST), which assists faculty in developing inclusive teaching practices.

Purdue College of Veterinary Medicine Hosts Reception to Welcome New Dean Bret Marsh

Faculty, staff and students gathered at a reception in the Veterinary Medical Library Friday, November 8, to help extend a warm welcome the new dean of the Purdue University College of Veterinary Medicine, Dr. Bret Marsh.  The event marked the conclusion of the first week on the job for Dr. Marsh, who just started in the role Monday, November 4, after wrapping-up 30 years of service as Indiana State Veterinarian – the state’s top-ranking animal health leader.

Awareness Week to Shine Spotlight on Antimicrobial Resistance Next Week

Antimicrobial resistance (AMR) is a growing, significant One Health issue across the world. The WHO estimates that AMR was directly responsible for 1.27 million global deaths and contributed to 4.95 million deaths, with additional significant economic costs. AMR affects all countries and all income groups, and to tackle this urgent problem, researchers, producers, and practitioners from all areas must address the critical shortage of new antimicrobial drugs, and the use of antimicrobial drugs in medicine, farming, and industry. The week of November 18-24 is US Antibiotic Awareness Week and World AMR Awareness Week, and the College of Veterinary Medicine is taking advantage of these national and global campaigns to raise awareness about AMR and antimicrobial stewardship, and to highlight some of the research and practices being conducted at the college to address AMR.

PVM Faculty Honored for Research Success with Purdue Seed for Success Acorn Awards

When Purdue University’s Office of Research honored the accomplishments and innovative ideas of a host of researchers this week, several Purdue Veterinary Medicine scholars were among those recognized. At a ceremony Wednesday, November 14, in the Purdue Memorial Union North and South Ballrooms, the annual Seed for Success Acorn Awards were presented to Purdue Principal Investigators (PIs) and co-PIs who secured research awards of $1 million or more for a single proposal in fiscal year 2024.

Unlocking the Mysteries of the Brain

Despite more than six decades of research in the field of neuroscience, many functions of the brain — the most complex organ in the human body — remain a mystery. Recent research conducted in the Purdue University College of Veterinary Medicine and the Bindley Bioscience Center revealed that scientists are one step closer to understanding the process that activates and deactivates specific proteins within our cells. This breakthrough could one day lead to enhanced treatments that may slow down or perhaps reverse the advance of neurogenerative diseases such as Alzheimer’s, Parkinson’s and multiple sclerosis.